MRVI - Maravai Lifesciences Holdings Inc

Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human disease research in the United States and internationally. The company is headquartered in San Diego, California.

52W High

$9.50

52W Low

$1.67

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.29

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

370.37

EV/EBITDA (<8 favorable)

1.77

EV/Revenue (<3 favorable)

2.08

P/S (TTM) (<3 favorable)

4.18

P/B (<3 favorable)

1.37

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

10.16%

Institutions (25–75% balanced)

90.18%

Shares Outstanding

144,678,000

Float

92,644,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

219,830,000

Gross Profit (TTM)

67,117,000

EPS (TTM)

-1.37

Profit Margin (>10% good)

-0.88%

Operating Margin (TTM) (higher better)

-0.75%

ROE (TTM) (>15% strong)

-0.55%

EPS YoY (Quarterly) (>10% good)

-0.33

Revenue YoY (Quarterly) (>8% good)

-0.32

Momentum

Bearish momentum

Value

-0.0086

-0.0229

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025